Resources

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: June 15, 2021

Incidence, Severity and Management of COVID‑19 Across Acutely Ill COVID‑19 Obstetrical Patients

Product: — Evidence Synthesis Network

Health Status Vulnerable Groups

esnetwork.ca Last Updated: May 6, 2021

Mobile On-Site COVID‑19 Vaccination of Naturally Occurring Retirement Communities by Neighbourhood Risk in Toronto

Product: — Science Table

Health Inequities Health Status Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: March 17, 2021

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies

Product: — Cochrane Library

Health Status Vulnerable Groups

www.cochranelibrary.com Last Updated: March 11, 2021

Also available in Français

COVID-19 Outcomes For Priority Populations And Settings

Product: — Evidence Synthesis Network

Health Inequities Low SES Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Last Updated: February 22, 2021

COVID-19 and Ontario’s Long-Term Care Homes

Product: — Science Table

Health Status Long-term & Community Care Long-term Care Vulnerable Groups

covid19-sciencetable.ca Last Updated: January 20, 2021

COVID-19 mRNA Vaccines for People With Cancer

Product: — Canadian Agency for Drugs and Technologies in Health

Health Status Vaccine Vaccines & Immunity Vulnerable Groups

covid.cadth.ca Last Updated: December 22, 2020

Also available in Français

Association Between Covid-19 And Vitamin D Levels

Product: — Evidence Synthesis Network

Health Status Vulnerable Groups

esnetwork.ca Last Updated: December 9, 2020

Economic Impact Of Non-Pharmaceutical Interventions During COVID-19

Product: — Evidence Synthesis Network

Cost Economics Non-drug Interventions

esnetwork.ca Last Updated: December 4, 2020

Synopsis for the Resumption of Colorectal and Cervical Cancer Screening during the Covid-19 pandemic

Product: — Canadian Agency for Drugs and Technologies in Health

Health Status Vulnerable Groups

covid.cadth.ca Last Updated: October 30, 2020

Also available in Français